Rabies vaccines shortage puts Delhi on brink of crisis
Decreased supply of anti-rabies vaccines (ARVs) in Delhi causes outbreak of the disease.
List view / Grid view
Decreased supply of anti-rabies vaccines (ARVs) in Delhi causes outbreak of the disease.
Building from the company’s best-selling SCIEX Triple Quad™ for over 10 years, users can now get triple quad sensitivity plus QTRAP® functionality in one system.
New supercomputing centres have been selected to support Europe's researchers, industry and businesses to design medicines.
A total of 48 US states are now suing Purdue Pharma, claiming they falsely marketed their opioid drug.
A treatment for amyloidosis has been pulled from clinical trials after failing to reach endpoints.
The FDA has given its approval to a new injection for cluster headaches which reduce frequency of attacks.
The UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI), has been launched at a BIO reception.
A new AI project marks the first time 10 pharmaceutical companies have agreed to share data to aid drug discovery.
The global contraceptive pill market is expected to increase to US$8.8 billion by 2024, report finds.
Novel influenza A vaccine has been administered to first patients in Phase IIb trial.
The global pharmaceutical intermediates market is likely to see year-on-year growth in 2019, by an estimated 3.6 percent rate.
The National Institute for Health and Care Excellence is recommending MSD’s Prevymis (letermovir) within the NHS.
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
The global biobetters market is set to increase due to demand for higher efficacy and safer drugs.
A research team from Scripps Research Translational Institute has published revealing figures in relation to drug prices in the US.